Pfizer Nears $7.3B Acquisition of Anti-Obesity Firm Metsera
Pfizer is nearing a $7.3 billion acquisition of Metsera, a company specializing in anti-obesity drugs, as part of its strategic expansion in the pharmaceutical sector.
Tag
Anti Obesity Drug
All articles tagged with #anti obesity drug
"Weight-Loss Drug Reduces Opioid Cravings: A Surprising Connection"
A small study presented at the American Association for the Advancement of Science conference found that the anti-obesity drug liraglutide significantly reduced opioid cravings in patients with opioid use disorder. The study, funded by the National Institute of Drug Abuse and pharma company Novo Nordisk, showed a 30% reduction in cravings over a three-week period, with potential for an additive effect when combined with buprenorphine. While the drug was found to be safe, gastrointestinal distress led to a high drop-out rate, suggesting the need for further investigation. Despite limitations, the findings suggest liraglutide could be a promising adjunct to existing treatments for opioid addiction.